fda semaglutide warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Approves Semaglutide to Reduce

Key Benefits CONVERT FAT TO ENERGY: This formula contains conjugated linoleic acid (CLA) and carnitine, two popular ingredients that have been show to work synergistically to help the body convert fat cells into energy

NICE guidance recommends GLP-1 receptor agonists as part of comprehensive diabetes management (NG28) and, in specific circumstances, for weight management (TA875) when lifestyle interventions alone have been insufficient

That can amount to more than $22,000 in medication costs per year

Medical Perspective If you start to experience side effects or they worsen, you should communicate this with your doctor